Skip to content

What is the difference between the old and new Primatene Mist?

4 min read

The original Primatene Mist, containing ozone-depleting CFC propellants, was removed from the market in 2011 as part of an international phase-out agreement. A reformulated version, featuring an environmentally friendly HFA propellant and a new inhaler design, was approved by the FDA and returned to shelves in 2018. This article details what is the difference between the old and new Primatene Mist, clarifying the changes for users.

Quick Summary

A comparison of the old and new Primatene Mist, covering changes to the propellant (CFC to HFA), device design, administration instructions, and approved age indication. Despite having the same active ingredient (epinephrine), the two products function differently and require distinct usage protocols for safety and efficacy.

Key Points

  • Propellant Change: The old inhaler used ozone-depleting CFCs, while the new version uses environmentally friendly HFA propellant.

  • Redesigned Device: The new Primatene Mist has a metal canister, a built-in spray indicator, and requires specific priming and cleaning procedures.

  • Altered Administration: The new product delivers a specific amount of epinephrine per spray and has a specific maximum daily administration limit.

  • Restricted Age Indication: The new inhaler is only approved for patients 12 years and older, unlike the old version which was approved for ages 4 and up.

  • Same Active Ingredient: Despite the changes, both the old and new products use epinephrine for the temporary relief of mild, intermittent asthma symptoms.

  • New Usage Protocols: Users must follow new, detailed instructions for priming, shaking, and daily cleaning to ensure the inhaler works correctly.

In This Article

The return of Primatene Mist to pharmacy shelves in 2018 was a significant development for individuals with mild, intermittent asthma seeking an over-the-counter treatment option. However, the reformulated product is not identical to the version that was discontinued in 2011. The primary drivers for the change were environmental regulations, which necessitated a complete overhaul of the device and its formulation. This guide breaks down the key distinctions between the old and new inhalers.

The Driving Force: A Change in Propellant

The most critical change between the two versions of Primatene Mist is the propellant used to deliver the medication. This shift was a direct result of international environmental protocols.

Why the Original Inhaler Was Removed

The original Primatene Mist, sold before 2011, used chlorofluorocarbon (CFC) propellants. CFCs were found to deplete the Earth's ozone layer, leading to the Montreal Protocol, an international treaty aimed at phasing out ozone-depleting substances. The United States' Clean Air Act of 1990 further solidified this effort, leading to the eventual removal of all CFC-based inhalers from the market, including Primatene Mist.

The Environmentally Friendly Alternative

The new Primatene Mist uses hydrofluoroalkane (HFA) propellants, which do not harm the ozone layer. This is the same type of propellant used in many modern prescription inhalers, like those containing albuterol. The switch to HFA was necessary for the product to receive FDA approval for reintroduction.

Comparing the Devices: Old vs. New

Beyond the propellant, the physical design and functional requirements of the inhaler device have been completely redesigned for the new version. Consumers familiar with the old product must read the instructions carefully to use the new one correctly.

Key Device Differences

  • The new inhaler features a metal canister, replacing the older version's glass container.
  • It includes a built-in spray indicator to show how many administrations remain, a feature not present on the old model.
  • The new device requires specific actions to be performed for proper use.

New Usage Instructions

The new Primatene Mist requires a specific set of instructions that must be followed for the device to work properly and deliver an accurate amount of medication. These steps were not required for the original product.

To use the new inhaler correctly, consumers must:

  • Activate the inhaler with a series of sprays before the first use.
  • Shake the inhaler before every administration.
  • Spray one puff into the air before each inhalation.
  • Clean the inhaler's mouthpiece with water after each day of use.

Administration and Age Indication Differences

Though both versions use epinephrine, the way the medication is delivered and the target age group have changed.

Administration

The new Primatene Mist delivers a specific amount of epinephrine per spray (0.125 mg) compared to the old CFC version (0.220 mg). However, a more efficient delivery system means the current administration amount provides comparable bronchodilator efficacy. The maximum recommended daily administration is also different:

  • Old Version (CFC): May be administered at certain intervals, not to exceed a specific number of administrations per day.
  • New Version (HFA): May be administered at certain intervals, not to exceed a specific number of administrations per day.

Age Indication

The approved age range for the new Primatene Mist is different. The FDA approved the reformulated product only for individuals 12 years of age and older. The older version was indicated for use by children as young as 4.

Comparison Table: Old vs. New Primatene Mist

Feature Old Primatene Mist (CFC) New Primatene Mist (HFA)
Propellant Chlorofluorocarbons (CFC) Hydrofluoroalkane (HFA)
Canister Material Glass Pressurized Metal
Active Ingredient Epinephrine Epinephrine
Epinephrine Amount/Spray 0.220 mg 0.125 mg
Device Features Basic, no spray indicator Includes built-in spray indicator
Usage Requirements Basic instructions Priming, shaking before each use, daily cleaning
Maximum Daily Administration Specific limitation per 24 hours Specific limitation per 24 hours
Age Indication 4 years and older 12 years and older
Market Dates Discontinued 2011 Approved 2018

The Active Ingredient: Epinephrine

Both the old and new Primatene Mist rely on the same active ingredient: epinephrine. Epinephrine is a bronchodilator that works by relaxing the muscles in the airways, making it easier to breathe. It is important to note that epinephrine is intended for temporary relief of mild, intermittent asthma symptoms, not as a replacement for prescription maintenance medication. Patients with more severe or persistent asthma should always consult a doctor for a proper treatment plan. For additional information on the drug facts for the current version, see the FDA website.

Conclusion: A Safer and Redesigned Option

In short, the difference between the old and new Primatene Mist is significant and goes far beyond a simple repackaging. The new version is a modern, environmentally conscious medication with an entirely redesigned delivery system. While it contains the same active ingredient, its use requires careful attention to the updated instructions regarding priming, shaking, and cleaning. The changes in administration protocols and age indication also underscore the importance of understanding the new product's limitations. Former users of the CFC version should thoroughly review the current product's labeling to ensure correct and safe use.

Frequently Asked Questions

The old Primatene Mist was removed from the market in 2011 because its chlorofluorocarbon (CFC) propellant was found to deplete the ozone layer. Its phase-out was part of a broader international effort to ban ozone-depleting substances.

Yes, both the old and new Primatene Mist use the same active ingredient, epinephrine, which is a bronchodilator for the temporary relief of mild asthma symptoms.

The new Primatene Mist delivers a specific amount of epinephrine per spray compared to the old version. However, the new HFA delivery system is more efficient, allowing the product to achieve comparable effectiveness.

The new Primatene Mist is a suspension formulation that requires shaking and priming before each use to ensure the medication is properly mixed and delivered. Daily cleaning is necessary to prevent medication buildup from clogging the device.

No, the new Primatene Mist is only approved for adults and children 12 years of age and older. The safety and efficacy of the product in younger children have not been established.

The new Primatene Mist is an over-the-counter (OTC) medication, just as the original was. It is intended for temporary relief of mild, intermittent asthma symptoms without a prescription.

No, Primatene Mist is designed for temporary relief of mild symptoms of intermittent asthma. It is not a substitute for prescription medication or emergency treatment for severe asthma attacks. A doctor should be consulted for worsening or severe asthma.

No, unlike the original glass canister, the new Primatene Mist comes in a pressurized metal canister. This new design is part of the redesigned delivery system.

Using the inhaler incorrectly by failing to shake and prime it can result in receiving an inaccurate or ineffective amount of medication. It is crucial to follow all instructions provided with the new product.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.